Joseph Allen

Joseph Allen

Joseph Allen is a Featured Contributor on IPWatchdog.com, and a 30-year veteran of national efforts to foster public/private sector commercialization partnerships, and author of numerous articles on technology management for national publications.

Joe served as a Professional Staff Member on the U.S. Senate Judiciary Committee with former Senator Birch Bayh (D-IN), and was instrumental in working behind the scenes to ensure passage of the historic Bayh-Dole Act. He is our resident Bayh-Dole expert, and will write frequently about Bayh-Dole and issues surrounding the commercialization of university research.

In 2008, Joe founded Allen & Associates, through which he offers consulting services assisting clients in technology transfer issues, including developing effective communication strategies with national policy makers.


Posts by Joseph Allen


Compulsory Licensing for Medicare Drugs– Another Bad Idea from Capitol Hill

Rep. Lloyd Doggett (D-TX) recently introduced the Medicare Negotiation and Competitive Licensing Act of 2018. Lest the title confuse you, by "competitive licensing" Rep. Doggett means compulsory licensing …
By Joseph Allen
1 year ago 42

Want a greater ROI for taxpayers? Restore the patent system, protect Bayh-Dole and cut the red tape strangling federal labs

Three events boosted our economic turnaround in the 1980's: the passage of Bayh-Dole, which injected the incentives of patent ownership into the federal R&D system; the …
By Joseph Allen
1 year ago 6

The Government Entrepreneur’s Dilemma   

Ironically, now that the Trump Administration's prioritizing economic as well as scientific returns on investment from federal research, one of EPA's best examples is gone. Others who …
By Joseph Allen
1 year ago 8

Increasing the ROI from the Federal Labs

The biggest complaint about federal labs is it's too hard to complete deals. Many federal labs must run pending agreements through byzantine departmental procedures. Companies wonder what's …
By Joseph Allen
1 year ago 6

Unleashing American Innovation, Oil States and Eroom’s Law

NCATS is working with industry to de-risk promising therapies by helping to take them further down the development pipeline. But the key ingredient remains finding a private …
By Joseph Allen
1 year ago 7

Dueling Visions of the Patent System, Dueling Visions for America

The article in IPWatchdog describing how the United States democratized the patent system, extending the right to own intellectual property to commoners, came to mind after reading …
By Joseph Allen
2 years ago 54

A Conversation with a Remarkable Man

This is not about intellectual property or tech transfer. Rather this chance meeting brought to mind Ernest Hemingway's saying: "Grace under pressure is the measure of a …
By Joseph Allen
2 years ago 8

A Fleeting Glimpse of Reason in the Drug Development Debate

Despite the difficulties, the private sector is far and away the best bet for developing the desperately needed medicines of the future. Government is a critical partner …
By Joseph Allen
2 years ago 2

Words of Wisdom

Here's a different kind of column to end the year. I always talk with taxi drivers. A few months ago while riding with an Ethiopian born cabbie …
By Joseph Allen
2 years ago 10

Another IP Professor Attack On Patenting

I was just thinking how often someone teaching intellectual property law leads the attack on the patent system when "Racing for academic glory and patents: Lessons from …
By Joseph Allen
2 years ago 21

Pity the Patients if Exclusive Licensing is Undermined

We've learned from experience that just because a theory's off base doesn't mean it won't take root, particularly when it involves patents and medicine. "No Vaccines Before …
By Joseph Allen
2 years ago 1

Think Twice Before Pulling the Plug on Tech Transfer

Most assaults on public/private sector R&D partnerships are launched by those who believe patents are inherently bad and that through some undefined magic publicly funded …
By Joseph Allen
2 years ago 0

Bernie Sander’s Really Bad Idea

Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention …
By Joseph Allen
2 years ago 14

Proposal from Senator King Won’t Reduce Drug Prices, Just Innovation

Many were stunned to learn that Senator Angus King (I-ME) included language undermining the Bayh-Dole Act in the report of the Senate Armed Services Committee as it …
By Joseph Allen
2 years ago 3

Academic Patent Licensing Helps Drive the U.S. Economy

What's even more impressive is the impacts on gross industry output and GDP are up 14% while  the number of U.S. jobs supported rose 12% since the previous …
By Joseph Allen
2 years ago 8